Skip to main content
OpenTrials

Clinical trial condition

Narcotic-Related Disorders

Explore clinical trials studying Narcotic-Related Disorders. Study availability and eligibility vary by location and protocol.

29 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Narcotic-Related Disorders trial results

Recruiting

GLP-1R Agonist Treatment for Opioid Use Disorder

NCT06548490

Conditions
Behavior, Behavior, Addictive, Chemically-Induced Disorders, +11 more
Locations
  • University of Maryland Baltimore Baltimore, Maryland, United States
  • Stanley Street Treatment and Resources Fall River, Massachusetts, United States
  • NYU Langone Health New York, United States
  • Pennsylvania Psychiatric Institute Harrisburg, Pennsylvania, United States
View Trial Details
Completed

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

NCT06023459

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations
  • AppleGate Recovery El Dorado El Dorado, Arkansas, United States
  • Southern Humboldt Community Healthcare District - Jerold Phelps Community Hospital Garberville, California, United States
  • Gibson Area Hospital and Health Services - Gibson Recovery Optimizing Wellness Gibson City, Illinois, United States
  • Penobscot Community Health Care Inc. - Seaport Community Health Center Belfast, Maine, United States
View Trial Details
Completed

Suvorexant for Opioid/Stimulant Co-use

NCT05546515

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations
  • Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women

NCT01965704

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations
  • UCSF, San Francisco General Hospital San Francisco, California, United States
  • Santa Clara Valley Medical Center San Jose, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Louisville Louisville, Kentucky, United States
View Trial Details

Related conditions